1. Home
  2. NBBK vs ARDX Comparison

NBBK vs ARDX Comparison

Compare NBBK & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBBK

NB Bancorp Inc.

HOLD

Current Price

$22.78

Market Cap

926.5M

Sector

N/A

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$3.59

Market Cap

975.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBBK
ARDX
Founded
1892
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
926.5M
975.9M
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
NBBK
ARDX
Price
$22.78
$3.59
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$23.50
$15.14
AVG Volume (30 Days)
275.8K
3.6M
Earning Date
04-22-2026
04-30-2026
Dividend Yield
1.43%
N/A
EPS Growth
25.23
N/A
EPS
0.90
N/A
Revenue
N/A
$2,607,000.00
Revenue This Year
$45.15
$37.75
Revenue Next Year
$4.18
$34.24
P/E Ratio
$25.42
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.84
$3.68
52 Week High
$23.47
$8.40

Technical Indicators

Market Signals
Indicator
NBBK
ARDX
Relative Strength Index (RSI) 54.42 27.70
Support Level $21.16 N/A
Resistance Level $23.47 $6.47
Average True Range (ATR) 0.51 0.13
MACD 0.02 0.04
Stochastic Oscillator 75.54 9.72

Price Performance

Historical Comparison
NBBK
ARDX

About NBBK NB Bancorp Inc.

NB Bancorp Inc operates as the holding company of Needham Bank. The group's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate and multifamily loans, one- to four-family residential real estate loans, construction and land development loans, commercial and industrial loans, consumer loans, and other related services.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: